Mycobacterial Infections Flashcards
Goals of TB Treatment is to NEVER
Treat w/ single drug or add single drug to failing regimen
Directly Observed Therapy
Preferred management strategy for ALL patients
For drug-resistant TB use
The daily regimen & DOT
Anti -TB 1st line Drugs
Ethambutol Isoniazid Pyrazinamide Rifabutin Rifampin Rifapentine
Anti - TB 2nd line Drugs
Bedaquiline Capreomycin Cycloserine Ethionamide p-Aminosalicyclic acid Streptomycin
4 regimens recommended for TB (drug susceptible) treatment are
Initial phase: standard 4 drugs INH, PZA, EMB, RIF for 2 months (1 excludes PZA)
Continuation phase: Additional 4 months or 7 months for some
Isoniazid: MOA
1) Most potent - don’t use as single agent
2) Pyridoxine synthetic analog
3) Bacteriostatic for stationary phase; Bactericidal for dividing phase
4) Intracellular bacteria
Isoniazid: PK
Oral - readily absorbed
Food disrupts absorption (Carbs, aluminum antacids)
In infected tissues
Glomerular filtration as metabolites
Isoniazid: Pt metabolism
1) N-acetylation & hydrolysis = inactive products
2) Slow acetylators excrete more of the parent compound = long half life
3) Rapid acetylators = short half life
4) Poor renal function = drug accumulation
5) Chronic liver disease decreases metabolism (reduce dose)
Isoniazid: drug interactions
Increases blood levels of phenytoin (dilatin) & disulfiram (antabuse)
Pyrazinamide: MOA
1) Pyrazine analog of Nicotinamide
2) Hydrolyzed becomes pyrazinoic acid
3) Bactericidal for dividing phase - unknown mechanism
4) Bacteria in lysosomes & macrophages
Pyrazinamide: PK
1) Oral >90% bioavailability
2) GI absorption
3) Found in lung epithelial lining fluid
4) Body distribution (CSF penetration)
5) Renal issues = poor metabolism
Issues of Pyrazinamide & Ethambutol
Gouty attacks
Urate retention
Ethambutol
1) TB, disseminated MAC, M. kansasii infection
2) Bacteriostatic
3) Arabinosyl transferase inhibition
Arabinosyl transferase inhibition =
Disrupts arabinogalactan cell wall formation
Ethambutol: PK
1) Oral ~ 80% BA
2) Body distribution (CSF penetration)
3) Glomerular filtration & Tubular secretion
4) Dose 3x a week in ESRD